LISATA
Live / Applied — Statement of use — response to non-final action entered (as of 09 Nov 2026)
What this means for you
Not registered yet, but its 22 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97377210
- Mark type
- Word mark
- Filed
- 22 Apr 2022
- Published for opposition
- 18 Apr 2023
- Attorney of record
- Karen Won
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in cancer, tumors; Pharmaceutical preparations for use in treating and managing diseases, disorders, and conditions involving oncology; Therapeutic pharmaceutical preparations for enhancing the targeting, delivery, and effectiveness of cancer treatments; Therapeutic agents for altering immunosuppressive tumor microenvironments
- Class 042 — Scientific and technological services: Research and development in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies and oncology; Providing medical scientific information in the fields of pharmaceuticals, biotechnology, cell therapies, drug delivery technologies
Owner
- LISATA THERAPEUTICS, INC., BASKING RIDGE, NJ, US
- Caladrius Biosciences, Inc., Basking Ridge, NJ, US
- Caladrius Biosciences, Inc., Basking Ridge, NJ, US
Prosecution history
- 09 Nov 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Nov 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Nov 2026 — ASSIGNED TO LIE
- 04 Nov 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Aug 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Aug 2026 — NON-FINAL ACTION E-MAILED
- 06 Aug 2026 — SU - NON-FINAL ACTION - WRITTEN
- 29 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Jun 2026 — USE AMENDMENT FILED
- 15 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 07 May 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 May 2026 — SOU EXTENSION 5 GRANTED
- 02 Dec 2025 — SOU EXTENSION 5 FILED
- 06 May 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED